13th March 2024|News, Uncategorized Partnership agreement with Morepen for SlimBiome® containing finished products
16th October 2023|News ProBiotix Health highlights LPLDL® and new products to support cardiometabolic health at SupplySide West
4th October 2023|News OptiBiotix to launch its finished product WellBiome® for the US market at SupplySide West
25th May 2023|News Consumers hungry for weight loss and an industry craving for innovation – what next for the injectable revolution?
9th May 2023|News ProBiotix Health launches new dual-action cholesterol reducing bi-layer tablet CholBiome®CH at Vitafoods Europe
9th May 2023|News OptiBiotix to launch new WellBiome® solution for wellbeing and healthy ageing consumer market at Vitafoods Europe 2023
27th February 2023|News OptiBiotix launches GoFigure® in Saudi Arabia to help combat ‘alarming’ obesity rates in population
23rd November 2022|News OptiBiotix: Scientific community must double-down on efforts to reduce cardiovascular risk following presentation at US Global Engage Conference
